Clinical Trial

Comparative Study Evaluating Safety and Effectiveness of ( Proton Pump Inhibitor Versus Vonoprazan ) Based Triple Therapy With or Without Zinc to Eradicate H. Pylori Infection

Not Yet Recruiting Phase 3
View on ClinicalTrials.gov →
Record status
This record was last updated December 24, 2025 (before its estimated April 2026 completion). Its status may not reflect the trial's current state.
Summary
this Study Evaluating Safety and Effectiveness of (Proton Pump Inhibitor versus Vonoprazan) Based Triple Therapy with or without Zinc to Eradicate H. pylori Infection
Protocol Amendment History 1 amendment
This ClinicalTrials.gov record has been amended once since 2025-11-27.
Trial Details
NCT Number NCT07275827
Lead Sponsor Tanta University
Conditions HELICOBACTER PYLORI INFECTIONS
Enrollment 88 participants
Start Date 2026-02-01
Primary Completion 2026-04 (estimated)
Study Completion 2026-10 (estimated)
Updated on ClinicalTrials.gov 2025-12-24